NCT00259935View on ClinicalTrials.gov

A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

October 4, 2004

Primary Completion Date

July 5, 2007

Study Completion Date

July 5, 2007

Conditions
Lung Cancer, Small Cell
Interventions
DRUG

topotecan

topotecan

Trial Locations (8)

10461

GSK Investigational Site, The Bronx

19111

GSK Investigational Site, Philadelphia

26506

GSK Investigational Site, Morgantown

37203

GSK Investigational Site, Nashville

78229

GSK Investigational Site, San Antonio

03756

GSK Investigational Site, Lebanon

1066 CX

GSK Investigational Site, Amsterdam

3584 CX

GSK Investigational Site, Utrecht

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00259935 - A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter